Epinephrine is recognized as first-line treatment for anaphylaxis, however it remains underutilized when treating reactions prior to going to the hospital. The reasons why it’s low and the actions needed for change are highlighted in our new infographic.
The insight highlighted in the infographic is based on a study co-authored by our Executive Director and members of our Healthcare Advisory Board. The study reports on the need for improvement in the use of epinephrine before going to the hospital (also referred to as “in community settings”) and what can be done to change the current picture.
We’ll be sharing this insight with the Ministries of Education, school communities, governments, and other stakeholders as a part of our discussions around:
- Policy for increased access to epinephrine
- Support of stock epinephrine auto-injectors (devices not prescribed to anyone and can be used in an emergency)
- Increased educational programming on anaphylaxis to reinforce when and how to treat it
Improvements in recognizing anaphylaxis and treating with epinephrine in community settings can lead to better outcomes, a goal shared by individuals with food allergy and healthcare professionals alike. You can:
- Check out the insights in our new infographic to understand more about the barriers to pre-hospital use of epinephrine and how to address them
- Ensure you know how to recognize anaphylaxis and when to use epinephrine:
Watch our #KnowItTreatIt encore presentation series of past online events and webinar
Take the free, 30-minute online course, Anaphylaxis in the Community, at AllergyAware.ca